Masimo invests in SHS portfolio company TNI medical
Tübingen/ Würzburg — Masimo, a manufacturer of non-invasive patient monitoring technologies based in Irvine, California, has agreed on a strategic investment with TNI medical AG, a medical technology company based in Würzburg, Germany. Funds advised by SHS Gesellschaft für Beteiligungsmanagement have been lead investors in TNI medical since 2010. Since then, the Tübingen-based medical technology and life science investor has supported the company’s growth strategy.
Patients with lung disease receive a stream of warm, moist air applied directly to the nose without condensation using TNI’s novel softFlow technology. The flow rate of the air as well as the humidity can be precisely adjusted and oxygen can be added if necessary. The system, consisting of an integrated flow generator, breathing circuit and patient interface, operates without pneumatic systems (i.e. without the use of externally supplied compressed air) and can be used both in the hospital and at home.
“The innovative products TNI has developed provide clinicians with important additional tools to treat the growing number of people affected by lung disease,” said Joe Kiani, founder, chairman and CEO of Masimo. “We are pleased to provide TNI with an investment that will enable the company to continue to commercialize its products in the large and rapidly growing high-flow nasal therapy market.”
“We are proud of our successful partnership with TNI medical, its management and employees. With the strategic investment of Masimo, TNI medical can benefit from a new partner with high expertise in innovative non-invasive monitoring technologies. We look forward to TNI’s future development,” says Reinhilde Spatscheck, managing partner at TNI’s lead investor SHS Gesellschaft für Beteiligungsmanagement.
About SHS Gesellschaft für Beteiligungsmanagement mbH
Tübingen-based SHS Gesellschaft für Beteiligungsmanagement invests in medical technology and life science companies with a focus on expansion financing, shareholder changes and succession situations. In doing so, SHS enters into both minority and majority shareholdings.
As an experienced industry investor, the company, which was founded in 1993, supports the growth of its portfolio companies through a network of collaborations, for example in the introduction of new products, regulatory issues or entry into additional markets. The German and international investors in SHS funds include professional pension funds, pension funds, strategic investors, funds of funds, family offices, entrepreneurs and the SHS management team. The equity investment of the AIFM-registered company is up to € 30 million, volumes exceeding this can be implemented with a network of co-investors. Currently, SHS is investing from its fifth fund. The fund has already received capital commitments of over 130 million euros. www.shs-capital.eu